United Therapeutics Corporation Share-based Payment Arrangement, Expense, after Tax
United Therapeutics Corporation (UTHR) reported Share-based Payment Arrangement, Expense, after Tax of $71.60 million for the 3-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2016-02-25
- United Therapeutics Corporation share-based payment arrangement, expense, after tax for the quarter ending 2015-12-31 was $71.60M, a 259.80% increase year-over-year.
- United Therapeutics Corporation share-based payment arrangement, expense, after tax for the quarter ending 2015-06-30 was $27.50M.
- United Therapeutics Corporation share-based payment arrangement, expense, after tax for the quarter ending 2015-03-31 was $145.70M.
- United Therapeutics Corporation share-based payment arrangement, expense, after tax for the quarter ending 2014-12-31 was $19.90M, a 82.10% decline year-over-year.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 3 month as first filed | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $71.60M 10-K · filed 2016-02-25 | ||||
| 2015-06-30 | $27.50M 10-K · filed 2016-02-25 | $173.20M derived: sum of 2 quarters · filed 2016-02-25 | $193.10M derived: sum of 3 quarters · filed 2016-02-25 | $315.20M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2015-03-31 | $145.70M 10-K · filed 2016-02-25 | $165.60M derived: sum of 2 quarters · filed 2016-02-25 | $287.70M derived: sum of 3 quarters · filed 2016-02-25 | ||
| 2014-12-31 | $19.90M 10-K · filed 2016-02-25 | $142.00M derived: sum of 2 quarters · filed 2016-02-25 | |||
| 2014-09-30 | $122.10M 10-K · filed 2016-02-25 | $140.30M 10-K · filed 2015-02-24 | |||
| 2013-12-31 | $111.20M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |